v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Collaboration revenue $ 148 $ 0 $ 148 $ 0
Operating expenses:        
Research and development cost 39,377 30,126 77,130 64,031
General and administrative 11,657 6,394 21,357 12,730
Total operating expenses 51,034 36,520 98,487 76,761
Loss from operations (50,886) (36,520) (98,339) (76,761)
Other income (expense):        
Interest income 4,189 1,049 6,618 2,306
Interest expense (210) (396) (502) (795)
Sublease income - related party 0 1,057 0 2,114
Change in fair value of simple agreement for future equity (5,556) 0 (5,556) 0
Total other (expense) income, net (1,577) 1,710 560 3,625
Net loss (52,463) (34,810) (97,779) (73,136)
Cumulative dividends on convertible preferred stock (14,492) (10,184) (32,181) (19,965)
Deemed dividend upon down-round of convertible preferred stock 0 0 (7,875) 0
Net loss allocable to common stockholders $ (66,955) $ (44,994) $ (137,835) $ (93,101)
Net loss per share allocable to common stockholders, basic $ (2.32) $ (22.28) $ (8.86) $ (46.13)
Net loss per share allocable to common stockholders, diluted $ (2.32) $ (22.28) $ (8.86) $ (46.13)
Weighted average common shares outstanding, basic 28,908,277 2,019,111 15,553,335 2,018,354
Weighted average common shares outstanding, diluted 28,908,277 2,019,111 15,553,335 2,018,354
Comprehensive loss:        
Net loss $ (52,463) $ (34,810) $ (97,779) $ (73,136)
Change in unrealized gains (losses) on marketable securities (18) (5) (18) (21)
Comprehensive loss $ (52,481) $ (34,815) $ (97,797) $ (73,157)